An immunoinformatics approach to epitope-based vaccine design against PspA in Streptococcus pneumoniae
Tóm tắt
Streptococcus pneumoniae (SPN) is the agent responsible for causing respiratory diseases, including pneumonia, which causes severe health hazards and child deaths globally. Antibiotics are used to treat SPN as a first-line treatment, but nowadays, SPN is showing resistance to several antibiotics. A vaccine can overcome this global problem by preventing this deadly pathogen. The conventional methods of wet-laboratory vaccine design and development are an intense, lengthy, and costly procedure. In contrast, epitope-based in silico vaccine designing can save time, money, and energy. In this study, pneumococcal surface protein A (PspA), one of the major virulence factors of SPN, is used to design a multi-epitope vaccine. For designing the vaccine, the sequence of PspA was retrieved, and then, phylogenetic analysis was performed. Several CTL epitopes, HTL epitopes, and LBL epitopes of PspA were all predicted by using several bioinformatics tools. After checking the antigenicity, allergenicity, and toxicity scores, the best epitopes were selected for the vaccine construction, and then, physicochemical and immunological properties were analyzed. Subsequently, vaccine 3D structure prediction, refinement, and validation were performed. Molecular docking, molecular dynamic simulation, and immune simulation were performed to ensure the binding between HLA and TLR4. Finally, codon adaptation and in silico cloning were performed to transfer into a suitable vector. The constructed multi-epitope vaccine showed a strong binding affinity with the receptor molecule TLR4. Analysis of molecular dynamic simulation, C-immune simulation, codon adaptation, and in silico cloning validated that our designed vaccine is a suitable candidate against SPN. The in silico analysis has proven the vaccine as an alternative medication to combat against S. pneumoniae. The designated vaccine can be further tested in the wet lab, and a novel vaccine can be developed.
Tài liệu tham khảo
Brooks LRK, Mias GI (2018) Streptococcus pneumoniae’s virulence and host immunity: aging, diagnostics, and prevention. Front Immunol 9:1366
Van der Poll T, Opal SM (2009) Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet (London, England) 374:1543–1556
Shaper M, Hollingshead SK, Benjamin WHJ, Briles DE (2004) PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected]. Infect Immun 72:5031–5040
Allegrucci M, Sauer K (2007) Characterization of colony morphology variants isolated from Streptococcus pneumoniae biofilms. J Bacteriol 189:2030–2038
Hammerschmidt S, Bethe G, Remane PH, Chhatwal GS (1999) Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae. Infect Immun 67:1683–1687
Mitchell AM, Mitchell TJ (2010) Streptococcus pneumoniae: virulence factors and variation. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 16:411–418
Ortqvist A, Hedlund J, Kalin M (2005) Streptococcus pneumoniae: epidemiology, risk factors, and clinical features. Semin Respir Crit Care Med 26:563–574
Zhao W, Pan F, Wang B, Wang C, Sun Y, Zhang T et al (2019) Epidemiology characteristics of Streptococcus pneumoniae from children with pneumonia in Shanghai: a retrospective study. Front Cell Infect Microbiol 9:258
Wahl B, O’Brien KL, Greenbaum A, Majumder A, Liu L, Chu Y et al (2018) Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15. Lancet Glob Heal 6:e744–e757
Von Mollendorf C, Tempia S, von Gottberg A, Meiring S, Quan V, Feldman C et al (2017) Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa. PLoS One 12:1–19
Kumar R, Arora N, Santosham M (2016) South Asia symposium on pneumococcal disease and the promise of vaccines – meeting report. Vaccine 34:2622–2626
Bahadori Z, Shafaghi M, Madanchi H, Ranjbar MM, Shabani AA, Mousavi SF (2022) In silico designing of a novel epitope ‑ based candidate vaccine against Streptococcus pneumoniae with introduction of a new domain of PepO as adjuvant. J Transl Med 20:1–28
Kim GL, Seon SH, Rhee DK (2017) Pneumonia and Streptococcus pneumoniae vaccine. Arch Pharm Res 40:885–893
Dorosti H, Eslami M, Nezafat N, Fadaei F, Ghasemi Y (2019) Designing self-assembled peptide nanovaccine against Streptococcus pneumoniae : an in silico strategy. Mol Cell Probes 48:101446
Kolla HB, Tirumalasetty C, Sreerama K, Ayyagari VS (2021) An immunoinformatics approach for the design of a multi-epitope vaccine targeting super antigen TSST-1 of Staphylococcus aureus. J Genet Eng Biotechnol 19:69
Elliott SL, Suhrbier A, Miles JJ, Lawrence G, Pye SJ, Le TT et al (2008) Phase I Trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis. J Virol 82:1448–1457
Shahab M, Hayat C, Sikandar R, Zheng G, Akter S (2022) In silico designing of a multi-epitope vaccine against Burkholderia pseudomallei: reverse vaccinology and immunoinformatics. J Genet Eng Biotechnol 20:100
Jahan Z, Deeba IM, Akter S, Rahman T, Nabi A, Yasmin M et al (2016) Immunogenicity of Streptococcus pneumoniae 74 kDa surface protein in rabbit model. Bangladesh J Microbiol 31:25–28
Munia M, Mahmud S, Mohasin M, Kibria KMK (2021) Informatics in medicine unlocked In silico design of an epitope-based vaccine against choline binding protein A of Streptococcus pneumoniae. Informatics Med Unlocked 23:100546
Tarahomjoo S, Ghaderi S (2017) Novel vaccines against Streptococcus pneumoniae based on the immunoprotective B-cell epitope region of pneumococcal choline binding protein D and Salmonella Enteritidis flagellin. Am J Microbiol Res, 5(6):118-123
Tarahomjoo S, Ghaderi S (2019) In silico design of a novel serotype independent vaccine against Streptococcus pneumoniae based on B-cell epitope regions of fibronectin binding protein, choline binding protein D, and D-alanyl-D-alanine carboxypeptidase. Lett Drug Des Discov 16(4):372–381. https://doi.org/10.2174/1570180815666180815150600
Dorosti H, Eslami M, Negahdaripour M, Ghoshoon MB, Gholami A, Heidari R et al (2019) Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccine. J Biomol Struct Dyn 37:3524–3535
McDaniel LS, Yother J, Vijayakumar M, McGarry L, Guild WR, Briles DE (1987) Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA). J Exp Med 165:381–394
Park SS, Gonzalez-Juarbe N, Martínez E, Hale JY, Lin YH, Huffines JT et al (2021) Streptococcus pneumoniae binds to host lactate dehydrogenase via PspA and PspC to enhance virulence. MBio 12:e00673
Ren B, Szalai AJ, Thomas O, Hollingshead SK, Briles DE (2003) Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae. Infect Immun 71:75–85
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403–410
Edgar RC (2004) MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32:1792–1797
Tamura K, Stecher G, Kumar S (2021) MEGA11: molecular evolutionary genetics analysis version 11. Mol Biol Evol 38:3022–3027
Doytchinova IA, Flower DR (2007) VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics 8:4
Dimitrov I, Bangov I, Flower DR, Doytchinova I (2014) AllerTOP vol 2–a server for in silico prediction of allergens. J Mol Model 20:2278
Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, Nielsen M (2007) Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics 8:424
Gupta S, Kapoor P, Chaudhary K, Gautam A, Kumar R, Raghava GPS et al (2013) In silico approach for predicting toxicity of peptides and proteins. PLoS One 8:e73957
Vita R, Mahajan S, Overton JA, Dhanda SK, Martini S, Cantrell JR et al (2019) The immune epitope database (IEDB): 2018 update. Nucleic Acids Res 47:D339–D343
Dhanda SK, Vir P, Raghava GPS (2013) Designing of interferon-gamma inducing MHC class-II binders. Biol Direct 8:30
Pandey RK, Bhatt TK, Prajapati VK (2018) Novel immunoinformatics approaches to design multi-epitope subunit vaccine for malaria by investigating anopheles salivary protein. Sci Rep 8:1–11
Islam SI, Mou MJ, Sanjida S, Tariq M, Nasir S, Mahfuj S (2022) Designing a novel mRNA vaccine against Vibrio harveyi infection in fish: an immunoinformatics approach. Genomics and Informatics 20:1–20
Abdellrazeq GS, Fry LM, Elnaggar MM, Bannantine JP, Schneider DA, Chamberlin WM et al (2020) Simultaneous cognate epitope recognition by bovine CD4 and CD8 T cells is essential for primary expansion of antigen-specific cytotoxic T-cells following ex vivo stimulation with a candidate Mycobacterium avium subsp. paratuberculosis peptide vaccine. Vaccine 38:2016–25
Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A (2003) ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 31:3784–3788
Magnan CN, Randall A, Baldi P (2009) SOLpro: accurate sequence-based prediction of protein solubility. Bioinformatics 25:2200–2207
Cheng J, Randall AZ, Sweredoski MJ, Baldi P (2005) SCRATCH: a protein structure and structural feature prediction server. Nucleic Acids Res 33(Web Server issue):W72-6
Heo L, Park H, Seok C (2013) GalaxyRefine: protein structure refinement driven by side-chain repacking. Nucleic Acids Res 41(Web Server issue):W384-8
Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8:477–486
Colovos C, Yeates TO (1993) Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci 2:1511–1519
Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C et al (2017) The ClusPro web server for protein-protein docking. Nat Protoc 12:255–278
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H et al (2000) The Protein Data Bank. Nucleic Acids Res 28:235–242
(2021) BIOVIA, Dassault Systèmes, Discovery studio, San Diego: Dassault Systèmes
The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC.
Laskowski RA, Jabłońska J, Pravda L, Vařeková RS, Thornton JM (2018) PDBsum: structural summaries of PDB entries. Protein Sci 27:129–134
López-Blanco JR, Aliaga JI, Quintana-Ortí ES, Chacón P (2014) iMODS: internal coordinates normal mode analysis server. Nucleic Acids Res 42(Web Server issue):W271-6
Rapin N, Lund O, Bernaschi M, Castiglione F (2010) Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS ONE 5:e9862
Madeira F, Pearce M, Tivey ARN, Basutkar P, Lee J, Edbali O, et al (2022) Search and sequence analysis tools services from EMBL-EBI in 2022. Nucleic Acids Res 50:gkac240
Grote A, Hiller K, Scheer M, Münch R, Nörtemann B, Hempel DC et al (2005) JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res 33(Web Server issue):W526-31
Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406–425
Mazumder L, Hasan MR, Fatema K, Islam MZ, Tamanna SK (2022) Structural and Functional Annotation and Molecular Docking Analysis of a Hypothetical Protein from Neisseria gonorrhoeae: An In-Silico Approach. Biomed Res Int. 2022;2022:4302625. https://doi.org/10.1155/2022/4302625
Luckheeram RV, Zhou R, Verma AD, Xia B (2012) CD4 +T cells: differentiation and functions. Clin Dev Immunol 2012:925135
El-Manzalawy Y, Dobbs D, Honavar VG (2017) In silico prediction of linear B-cell epitopes on proteins. Methods Mol Biol 1484:255–264
Akter S, Shahab M, Sarkar MMH, Hayat C, Banu TA, Goswami B et al (2022) Immunoinformatics approach to epitope-based vaccine design against the SARS-CoV-2 in Bangladeshi patients. J Genet Eng Biotechnol 20:136